AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35545982 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to 432Hz music
Number of subjects: 54
Study 35545982 — intervention group
Group type: COMPARATOR
Intervention: Liberal activity (control group)
Number of subjects: 54
Study 35399551 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based diet and PA promotion intervention based on self-determination theory and motivational interviewing
Number of subjects: 1142
Study 33625064 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir with emtricitabine plus tenofovir alafenamide (TAF)
Number of subjects: 314
Study 33625064 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir with emtricitabine plus tenofovir disoproxil fumarate (TDF)
Number of subjects: 314
Study 33625064 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 314
Study 33625064 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (TAF)
Number of subjects: 314
Study 33625064 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 314
Study 33049433 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical prediction
Number of subjects: 151
Study 33049433 — intervention group
Group type: COMPARATOR
Intervention: Clinical judgment (recommended treatment)
Number of subjects: 151
Study 33049433 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 151
Study 33049433 — intervention group
Group type: COMPARATOR
Intervention: Cognitive therapy (CT)
Number of subjects: 151
Study 32005104 — intervention group
Group type: EXPERIMENTAL
Intervention: Kuchi-kara Taberu index (KT index) used in the intervention group
Number of subjects: 112
Study 32005104 — intervention group
Group type: COMPARATOR
Intervention: MDCC program (control group)
Number of subjects: 112
Study 32866480 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic balloon dilation
Number of subjects: 150
Study 32866480 — intervention group
Group type: COMPARATOR
Intervention: No dilation (control group)
Number of subjects: 150
Study 35253709 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest combined with correct posture, eye rest and self-stretching
Number of subjects: 44
Study 35253709 — intervention group
Group type: COMPARATOR
Intervention: Rest only (Control)
Number of subjects: 44
Study 33802913 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended CBT
Number of subjects: 129
Study 33802913 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face CBT
Number of subjects: 129
Study 33802913 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 129
Study 34524145 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART
Number of subjects: 1023
Study 33243160 — intervention group
Group type: EXPERIMENTAL
Intervention: RS‐2 & usual care
Number of subjects: 60
Study 33243160 — intervention group
Group type: EXPERIMENTAL
Intervention: RS‐2 & aerobic exercise
Number of subjects: 60
Study 33243160 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cornstarch) & usual care
Number of subjects: 60
Study 33243160 — intervention group
Group type: COMPARATOR
Intervention: Placebo & exercise
Number of subjects: 60
Study 35311687 — intervention group
Group type: EXPERIMENTAL
Intervention: blended cognitive behavioral therapy (bCBT)
Number of subjects: 943
Study 35311687 — intervention group
Group type: COMPARATOR
Intervention: treatment-as-usual (TAU)
Number of subjects: 943
Study 32130302 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori positive individuals
Number of subjects: 63
Study 32130302 — intervention group
Group type: COMPARATOR
Intervention: Functional dyspeptic patients (cases)
Number of subjects: 63
Study 35536715 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Homes/Healthy Families intervention
Number of subjects: 114
Study 34230002 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoluminal radiofrequency ablation prior to metal stent insertion
Number of subjects: 76
Study 34230002 — intervention group
Group type: COMPARATOR
Intervention: Self-expandable metal stent insertion
Number of subjects: 76
Study 34230002 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoluminal radiofrequency ablation prior to metal stent insertion (cholangiocarcinoma subgroup)
Number of subjects: 76
Study 36194256 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact umbilical cord milking (UCM)
Number of subjects: 73
Study 36194256 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (ECC)
Number of subjects: 73
Study 33191157 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication reconciliation by a pharmacy team
Number of subjects: 221
Study 33191157 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 221
Study 35611515 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupressure
Number of subjects: 44
Study 35611515 — intervention group
Group type: EXPERIMENTAL
Intervention: Wristband acupressure
Number of subjects: 44
Study 35611515 — intervention group
Group type: COMPARATOR
Intervention: Placebo manual acupressure
Number of subjects: 44
Study 35611515 — intervention group
Group type: COMPARATOR
Intervention: Placebo wristband acupressure
Number of subjects: 44
Study 35611515 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional antiemetic drug use
Number of subjects: 44
Study 33023788 — intervention group
Group type: EXPERIMENTAL
Intervention: Let's Choose Ourselves with distractions in the simulator protocol at baseline
Number of subjects: 60
Study 33023788 — intervention group
Group type: EXPERIMENTAL
Intervention: Let's Choose Ourselves with no distractions
Number of subjects: 60
Study 33023788 — intervention group
Group type: COMPARATOR
Intervention: Attention control intervention on healthy eating with distractions
Number of subjects: 60
Study 33023788 — intervention group
Group type: COMPARATOR
Intervention: Attention control with no distractions
Number of subjects: 60
Study 33023788 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported risky driving behaviors
Number of subjects: 60
Study 33110039 — intervention group
Group type: EXPERIMENTAL
Intervention: E2/P4 1/100 mg/mg
Number of subjects: 726
Study 33110039 — intervention group
Group type: EXPERIMENTAL
Intervention: E2/P4 0.5/100 mg/mg
Number of subjects: 726
Study 33110039 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study 33215755 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediately loaded implants with a provisional fixed prosthesis
Number of subjects: 26
Study 33215755 — intervention group
Group type: COMPARATOR
Intervention: Conventionally loaded implants
Number of subjects: 26
Study 33215755 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (immediate and conventional loading)
Number of subjects: 26
Study 32061974 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated MPFL sectioning
Number of subjects: 12
Study 32061974 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete proximal medial patellar restraint (PMPR) sectioning
Number of subjects: 12
Study 32061974 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete sectioning following isolated MPFL sectioning
Number of subjects: 12
Study 32061974 — intervention group
Group type: COMPARATOR
Intervention: Intact state
Number of subjects: 12
Study 32061974 — intervention group
Group type: COMPARATOR
Intervention: Lateral retinacular release
Number of subjects: 12
Study 35642464 — intervention group
Group type: EXPERIMENTAL
Intervention: Early computed tomography coronary angiography (CTCA)
Number of subjects: 1748
Study 35642464 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac troponin elevation
Number of subjects: 1748
Study 35642464 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation cardiac troponin
Number of subjects: 1748
Study 33065462 — intervention group
Group type: EXPERIMENTAL
Intervention: pSUVmax < 14.4
Number of subjects: 133
Study 33065462 — intervention group
Group type: EXPERIMENTAL
Intervention: pSUVmax 14.4−17.5
Number of subjects: 133
Study 33065462 — intervention group
Group type: EXPERIMENTAL
Intervention: pSUVmax > 17.5
Number of subjects: 133
Study 34144359 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-abrasion with 110 µm Al2O3 particles (AlOx)
Number of subjects: 30
Study 34144359 — intervention group
Group type: COMPARATOR
Intervention: No surface treatment (CTRL)
Number of subjects: 30
Study 32232495 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patient-based training
Number of subjects: 20
Study 32232495 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patient-based training (after crossover)
Number of subjects: 20
Study 32232495 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 20
Study 35150243 — intervention group
Group type: COMPARATOR
Intervention: Healthy non-depressed adults
Number of subjects: 54
Study 35150243 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with major depressive disorder
Number of subjects: 54
Study 35150243 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 200 mg
Number of subjects: 54
Study 35150243 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 100 mg
Number of subjects: 54
Study 35150243 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 54
Study 35150243 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine D2/D3 receptor availability
Number of subjects: 54
Study 33326648 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous tibial nerve stimulation
Number of subjects: 30
Study 33326648 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study 32611448 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophagectomy
Number of subjects: 176
Study 32611448 — intervention group
Group type: COMPARATOR
Intervention: Definitive chemoradiotherapy (dCRT)
Number of subjects: 176
Study 34965642 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 155
Study 34965642 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 155
Study 34965642 — intervention group
Group type: COMPARATOR
Intervention: Asthma group (ICS and montelukast combined)
Number of subjects: 155
Study 32403066 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 12 weeks
Number of subjects: 0
Study 616781134 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-month physical activity intervention
Number of subjects: 154
Study 616781134 — intervention group
Group type: COMPARATOR
Intervention: Waitlist-control condition
Number of subjects: 154
Study 616781134 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-month physical activity intervention (among obese participants)
Number of subjects: 154
Study 36457044 — intervention group
Group type: EXPERIMENTAL
Intervention: InTSHA (Interactive Transition Support for Adolescents Living with HIV) - a multi-module, moderated WhatsApp-based intervention
Number of subjects: 21
Study 32308037 — intervention group
Group type: EXPERIMENTAL
Intervention: Message designed to convey source expertise
Number of subjects: 1000
Study 33590270 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing intervention
Number of subjects: 35
Study 32452818 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-delivered just-in-time planning intervention
Number of subjects: 136
Study 32452818 — intervention group
Group type: COMPARATOR
Intervention: Assessment only (control)
Number of subjects: 136
Study 36017827 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-day rivastigmine transdermal patch (RID-TDS), applied on a 4-3-4 day regimen for 11 consecutive days.
Number of subjects: 57
Study 36017827 — intervention group
Group type: COMPARATOR
Intervention: Exelon® transdermal patch, applied daily for 11 consecutive days.
Number of subjects: 57
Study 34147462 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-group-based intervention (IG)
Number of subjects: 543
Study 34147462 — intervention group
Group type: COMPARATOR
Intervention: Self-management control group (CG)
Number of subjects: 543
Study 36106868 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete Mesocolic Excision (CME)
Number of subjects: 390
Study 36106868 — intervention group
Group type: COMPARATOR
Intervention: Non-Complete Mesocolic Excision (NCME)
Number of subjects: 390
Study 32682361 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound therapy (US)
Number of subjects: 40
Study 32682361 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 40
Study 32682361 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 40
Study 36155117 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus letrozole
Number of subjects: 340
Study 36155117 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus letrozole
Number of subjects: 340
Study 33158772 — intervention group
Group type: EXPERIMENTAL
Intervention: Mogamulizumab
Number of subjects: 372
Study 33158772 — intervention group
Group type: COMPARATOR
Intervention: Vorinostat
Number of subjects: 372
Study 35351835 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin perfusion
Number of subjects: 13
Study 35351835 — intervention group
Group type: COMPARATOR
Intervention: Saline perfusion
Number of subjects: 13
Study 34758251 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alteplase followed by EVT
Number of subjects: 539
Study 34758251 — intervention group
Group type: COMPARATOR
Intervention: EVT alone
Number of subjects: 539
Study 32320401 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat (10-60 mg daily)
Number of subjects: 483
Study 32320401 — intervention group
Group type: COMPARATOR
Intervention: Control (non-pharmacological lifestyle modification)
Number of subjects: 483
Study 35357763 — intervention group
Group type: EXPERIMENTAL
Intervention: 595-nm pulsed dye laser
Number of subjects: 90
Study 35357763 — intervention group
Group type: COMPARATOR
Intervention: Microwave tissue coagulation
Number of subjects: 90
Study 35357763 — intervention group
Group type: COMPARATOR
Intervention: Liquid nitrogen cryotherapy
Number of subjects: 90
Study 32546192 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary outcome data
Number of subjects: 18
Study 32546192 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 18
Study 32546192 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-outcome data
Number of subjects: 18
Study 33433071 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture-fixation mucopexy (SF), N=60
Number of subjects: 123
Study 33433071 — intervention group
Group type: COMPARATOR
Intervention: Milligan-Morgan hemorrhoidectomy (MM), N=63
Number of subjects: 123
Study 33179359 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft contact lens wear
Number of subjects: 963
Study 34821978 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish
Number of subjects: 67
Study 34821978 — intervention group
Group type: EXPERIMENTAL
Intervention: Pastes containing CPP-ACP
Number of subjects: 67
Study 34821978 — intervention group
Group type: EXPERIMENTAL
Intervention: Pastes containing CPP-ACFP
Number of subjects: 67
Study 34821978 — intervention group
Group type: COMPARATOR
Intervention: Control (oral hygiene motivation only)
Number of subjects: 67
Study 35230051 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 0
Study 35230051 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32147225 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 μg salbutamol
Number of subjects: 30
Study 32147225 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy age- and gender-matched)
Number of subjects: 30
Study 32757777 — intervention group
Group type: EXPERIMENTAL
Intervention: Local corticosteroid injections
Number of subjects: 163
Study 32757777 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 163
Study 33973551 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy (three cycles of full-dose anthracycline and ifosfamide)
Number of subjects: 0
Study 33973551 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms for risk prediction
Number of subjects: 0
Study 33973551 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative systemic treatment
Number of subjects: 0
Study 35275606 — intervention group
Group type: EXPERIMENTAL
Intervention: In-clinic visit model
Number of subjects: 0
Study 35275606 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person group sessions
Number of subjects: 0
Study 35275606 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone group sessions
Number of subjects: 0
Study 35275606 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes patients on insulin
Number of subjects: 0
Study 35275606 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes patients not on insulin
Number of subjects: 0
Study 35275606 — intervention group
Group type: COMPARATOR
Intervention: Diabetes group
Number of subjects: 0
Study 32945993 — intervention group
Group type: EXPERIMENTAL
Intervention: Rare gene variants in women with severe OHSS (grades 4 and 5)
Number of subjects: 12
Study 32945993 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathway analysis of OHSS variant lists
Number of subjects: 12
Study 32945993 — intervention group
Group type: COMPARATOR
Intervention: Matched controls developing no signs of OHSS (Golan grade 0)
Number of subjects: 12
Study 35627382 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person counseling (PE)
Number of subjects: 961
Study 35627382 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based BAI (CO)
Number of subjects: 961
Study 35627382 — intervention group
Group type: COMPARATOR
Intervention: Assessment only
Number of subjects: 961
Study 34271366 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake
Number of subjects: 415
Study 34271366 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D intake
Number of subjects: 415
Study 34271366 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D status at 13 weeks’ gestation
Number of subjects: 415
Study 34271366 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D status at 28 weeks’ gestation
Number of subjects: 415
Study 34271366 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D status at 5-year follow-up
Number of subjects: 415
Study 34357396 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hour infusion of Vasoactive Intestinal Polypeptide (VIP)
Number of subjects: 21
Study 34357396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 36054685 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based eLearning
Number of subjects: 0
Study 36054685 — intervention group
Group type: COMPARATOR
Intervention: Slide-based eLearning
Number of subjects: 0
Study 34243157 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic third ventriculostomy plus choroid plexus cauterization (ETV+CPC)
Number of subjects: 100
Study 34243157 — intervention group
Group type: COMPARATOR
Intervention: Ventriculoperitoneal shunt (VPS)
Number of subjects: 100
Study 34243157 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ETV+CPC and VPS (analyzed together)
Number of subjects: 100
Study 33354337 — intervention group
Group type: COMPARATOR
Intervention: Weight Watchers (WW) online platform alone
Number of subjects: 146
Study 33354337 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Watchers (WW) enhanced with Experience Success (WW + ES) programme
Number of subjects: 146
Study 35925531 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention for NF
Number of subjects: 228
Study 35925531 — intervention group
Group type: EXPERIMENTAL
Intervention: NF1
Number of subjects: 228
Study 35925531 — intervention group
Group type: EXPERIMENTAL
Intervention: SCHW
Number of subjects: 228
Study 32183345 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance with the 2018 WCRC/AICR cancer prevention recommendations
Number of subjects: 398
Study 32183345 — intervention group
Group type: EXPERIMENTAL
Intervention: Limiting consumption of fast foods, sugar-sweetened drinks, and alcohol
Number of subjects: 398
Study 33849382 — intervention group
Group type: COMPARATOR
Intervention: Intralesional triamcinolone (Group-A, control)
Number of subjects: 160
Study 33849382 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional verapamil (Group-B)
Number of subjects: 160
Study 33849382 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional 5-fluorouracil (Group-C)
Number of subjects: 160
Study 33849382 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional platelet-rich plasma (Group-D)
Number of subjects: 160
Study 32347414 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention strategies used to facilitate participant engagement in follow‐up assessments
Number of subjects: 341
Study 32347414 — intervention group
Group type: EXPERIMENTAL
Intervention: High school diploma
Number of subjects: 341
Study 32347414 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment at community centers
Number of subjects: 341
Study 32347414 — intervention group
Group type: EXPERIMENTAL
Intervention: Less severe mental health condition
Number of subjects: 341
Study 32170727 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based written information and information to doctor recommending smoking cessation (group 4)
Number of subjects: 376
Study 32170727 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific information)
Number of subjects: 376
Study 34259328 — intervention group
Group type: EXPERIMENTAL
Intervention: Core exercise training (Ex)
Number of subjects: 39
Study 34259328 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration with core exercise (WBVEx)
Number of subjects: 39
Study 34259328 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 34127609 — intervention group
Group type: EXPERIMENTAL
Intervention: Change-of-direction technique modification intervention
Number of subjects: 27
Study 34127609 — intervention group
Group type: COMPARATOR
Intervention: Normal training (control group)
Number of subjects: 27
Study 32331036 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray + oral antidepressant (ESK+AD)
Number of subjects: 223
Study 32331036 — intervention group
Group type: COMPARATOR
Intervention: Oral antidepressant + placebo nasal spray (AD+PBO)
Number of subjects: 223
Study 36279133 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextualized clinical decision support (CDS) tools in the electronic health record (EHR)
Number of subjects: 452
Study 36279133 — intervention group
Group type: COMPARATOR
Intervention: Contextualized care plans
Number of subjects: 452